| US 7,572,443 B2 | ||
| Anti-PECAM therapy for metastasis suppression | ||
| Robert Debs, Mill Valley, Calif. (US) | ||
| Assigned to California Pacific Medical Center, San Francisco, Calif. (US) | ||
| Filed on Nov. 12, 2004, as Appl. No. 10/988,423. | ||
| Claims priority of provisional application 60/519986, filed on Nov. 13, 2003. | ||
| Prior Publication US 2005/0186213 A1, Aug. 25, 2005 | ||
| Int. Cl. A61K 39/00 (2006.01); A61K 39/395 (2006.01) | ||
| U.S. Cl. 424—130.1 [424/277.1; 424/141.1] | 11 Claims |
| 1. A method for repressing metastasis of a neoplastic cell, the method comprising administering a therapeutically effective amount of an anti-PECAM antibody via systemic administration to a mammal having one or more metastases. |